BIOMAT Database Logo BIOMAT Database Logo

A Rare Case of Blue-Gray Discoloration Induced by Low-Dose Amiodarone. 2023

Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Department of Medicine.

Amiodarone is increasingly used in cardiology due to convenient dosing, low frequency of pro-arrhythmic effects, and good short term tolerance without significant hypotension. However, chronic use is associated with multisystem toxic side effects. We describe a rare case of amiodarone induced blue-gray skin discoloration.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D064420 Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. Drug-Related Side Effects and Adverse Reaction,Adverse Drug Event,Adverse Drug Reaction,Drug Side Effects,Drug Toxicity,Side Effects of Drugs,Toxicity, Drug,Adverse Drug Events,Adverse Drug Reactions,Drug Event, Adverse,Drug Events, Adverse,Drug Reaction, Adverse,Drug Reactions, Adverse,Drug Related Side Effects and Adverse Reaction,Drug Related Side Effects and Adverse Reactions,Drug Side Effect,Drug Toxicities,Effects, Drug Side,Reactions, Adverse Drug,Side Effect, Drug,Side Effects, Drug,Toxicities, Drug

Related Publications

Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Amiodarone-related blue-gray skin discoloration.
April 2019, Anatolian journal of cardiology,
Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Blue-gray discoloration of the face. Amiodarone-induced cutaneous hyperpigmentation.
March 1989, Archives of dermatology,
Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Reversibility of blue-gray cutaneous discoloration from amiodarone.
July 1991, Mayo Clinic proceedings,
Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Minocycline-Induced Blue-Gray Discoloration.
August 2017, Skin appendage disorders,
Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Amiodarone-induced blue-gray syndrome.
September 2000, The Annals of pharmacotherapy,
Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
A blue-gray subungual discoloration.
July 2007, Archives of dermatology,
Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Blue-gray discoloration of the skin.
October 2011, American family physician,
Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Amiodarone-induced Hemoptysis: A Rare Presentation of Amiodarone-induced Pulmonary Toxicity Occurs at a Low Dose.
July 2019, Cureus,
Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Images in cardiovascular medicine. The blue man: amiodarone-induced skin discoloration.
February 2006, Circulation,
Arpanjeet Kaur, and Davendra Mehta, and Kiran Mahmood, and Jacqueline Tamis-Holland
Gray-blue discoloration of the proximal nail beds.
May 2023, JAAD case reports,
Copied contents to your clipboard!